Pathogenesis of chronic heart failure in rats based on ferroptosis-mediated oxidative stress and intervention effect of Shenfu Injection.
10.19540/j.cnki.cjcmm.20230601.702
- Author:
Zi-Yi WANG
1
;
Qian ZHANG
1
;
Jin GUO
1
;
Shu-Min HUANG
2
;
Li-Chong MENG
1
;
Zhi-Xi HU
1
Author Information
1. Hunan University of Chinese Medicine Changsha 410208, China.
2. the Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine Fuzhou 350003, China.
- Publication Type:Journal Article
- Keywords:
Shenfu Injection;
chronic heart failure;
ferroptosis;
oxidative stress
- MeSH:
Animals;
Rats;
Antioxidants;
Reactive Oxygen Species;
Cyclooxygenase 2;
Ferroptosis;
NF-E2-Related Factor 2;
Tumor Suppressor Protein p53;
Heart Failure/genetics*;
Oxidative Stress;
Chronic Disease;
Glutathione;
Fibrosis;
Iron;
RNA, Messenger;
Lipids
- From:
China Journal of Chinese Materia Medica
2023;48(19):5285-5293
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to investigate the pathogenesis of chronic heart failure based on ferroptosis-mediated oxidative stress and predict the targets of Shenfu Injection in treating chronic heart failure. A rat model of chronic heart failure was established by the isoproterenol induction method. According to the random number table method, the modeled rats were assigned into three groups: a model group, a Shenfu Injection group, and a ferrostatin-1(ferroptosis inhibitor) group. In addition, a normal group was designed. After 15 days of intervention, the cardiac mass index and left ventricular mass index were determined. Echocardiography was employed to eva-luate the cardiac function. Hematoxylin-eosin staining and Masson staining were employed to reveal the pathological changes and fibrosis of the heart, and Prussian blue staining to detect the aggregation of iron ions in the myocardial tissue. Transmission electron microscopy was employed to observe the mitochondrion ultrastructure in the myocardial tissue. Colorimetry was adopted to measure the levels of iron metabolism, lipid peroxidation, and antioxidant indicators. Flow cytometry was employed to measure the content of lipid-reactive oxygen species(ROS) and the fluorescence intensity of ROS. Western blot and RT-qPCR were employed to determine the protein and mRNA levels, respectively, of ferroptosis-related factors in the myocardial tissue. The results showed that the rats in the model group had reduced cardiac function, elevated levels of total iron and Fe~(2+), lowered level of glutathione(GSH), increased malondialdehyde(MDA), decreased superoxide dismutase(SOD) and glutathione peroxidase(GSH-Px), and rising levels of ROS and lipid-ROS. In addition, the model group showed fibrous tissue hyperplasia with inflammatory cell infiltration and myocardial fibrosis, iron ion aggregation, and characteristic mitochondrial changes specific for iron death. Moreover, the model group showcased upregulated protein and mRNA levels of p53 and COX2 and downregulated protein and mRNA levels of GPX4, FTH1, SLC7A11, and Nrf2 in the myocardial tissue. The intervention with Shenfu Injection significantly improved the cardiac function, recovered the iron metabolism, lipid peroxidation, and antioxidant indicators, decreased iron deposition, improved mitochondrial structure and function, and alleviated inflammatory cell infiltration and fibrosis. Furthermore, Shenfu Injection downregulated the mRNA and protein levels of p53 and COX2 and upregulated the mRNA and protein levels of GPX4, FTH1, SLC7A11, and Nrf2 in the myocardial tissue. Shenfu Injection can improve the cardiac function by regulating iron metabolism, inhibiting ferroptosis, and reducing oxidative stress injury.
